OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Registered number: 02620761 Charity number: 1006733

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1
Trustees' Report 2 - 11
Trustees' Responsibilities Statement 12
Independent Examiner's Report 13
Statement of Financial Activities 14
Balance Sheet 15
Statement of Cash Flows 16
Notes to the Financial Statements 17 - 31

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2025

Trustees

Julie Thallon - Chair Rachel King Wiqas Valji Meryl Davies Professor Alf Collins Tom Grinyer Mark Blaney – Treasurer (appointed 1st January 2025) Teena Chowdhury (appointed 1st January 2025) Julia Ross (appointed 1st January 2025) Carolin Ott (appointed 1st August 2025) Suzanne White (tenure ended 1st May 2025) Company registered number 02620761 Charity registered number 1006733 Registered office 32 Byron Hill Road Attn The Patients Association C/O A-Spire Business Partners Harrow On The Hill Middx HA2 0HY Chief Executive Officer Rachel Power and Company Secretary Independent Examiner MHA Chartered Accountants MHA House Charter Court Swansea Enterprise Park Swansea SA7 9FS

Page 1

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2025

Introduction by Julie Thallon, Chair of the Patients Association

The health and care system is at a pivotal moment. The 10-Year Health Plan for England promises a revolution in patient power - shifting care from hospitals to communities, from analogue to digital, from treatment to prevention. We welcome that ambition. But any transformation designed without patients is transformation that will fail them.

That is why the Patients Association exists. No other organisation does what we do: independent of the NHS, independent of any condition, we exist solely to ensure that what patients experience shapes the decisions that affect them.

In 2025 we put that into practice for another year.

The 10-Year Health Plan working group reports, published in January, cited our Digital Coalition work on digital health inequalities and our consultation response in the Plan’s public and patient engagement report: external recognition that patient voices, brought by us are shaping national policy.

As part of our ongoing work on health equity, patients in deprived and coastal communities told us clearly and consistently that they could not get GP appointments despite some living with the greatest health needs of anyone in the country. That patient experience sat at the heart of our Bristol Myers Squibb-funded health equity project, one of our most significant pieces of work in 2025, and it led directly to one of our core recommendations: that the Carr-Hill formula, the mechanism that determines how funding is allocated to GP practices across England must be reformed. For decades the formula has systematically underfunded practices in the most deprived areas, the very places where patients need care most. When the government announced a review of the formula, we welcomed it as a sign that those patient voices had been heard. This project also created an animation and information resources that were received positively from smaller local patient groups. The groups then asked us to consider translating these resources to support their communities and we are delighted to have received funding to do so in early 2026.

When the government needed to understand what patients expected from a national data pact, they commissioned us to find out. The focus groups we ran formed the basis of a draft data pact for patients and the public to review through a series of public deliberations. The first summary report of these deliberations was published in 2025 by NHS England and provides details on patient feedback by the Patients Association and how it has helped to shape public conversations around health data.

Our impact is also reflected in our reach and activity over the year. Our membership grew to 5,330. Our helpline handled over 4,200 enquiries. Patient Partnership Week attracted 864 attendees across seven webinars, a 74% increase on the previous year, with Sir Jim Mackey, Chief Executive of NHS England, among the speakers. We delivered 18 commissioned projects and built partnerships with communities that the system too often overlooks.

2025 was a financially challenging year for us and for the charity sector as a whole. The NHS spending freeze, a competitive funding environment, and shifting pharmaceutical pricing all affected our income.

With the generous pro-bono support of the Berkeley Partnership, we developed a 2026–2030 strategy built around four core services and a clearer account of the impact we create. 2026 is our foundational year. The transformation we are asking of the NHS, we are also asking of ourselves.

I am proud of what we have achieved together and the difference this is making for patients. Thank you to our staff, trustees, volunteers, members, partners, and supporters who make our work possible.

Julie Thallon (Chair)

Page 2

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees present their annual report together with the financial statements of the Charity for the 1st January 2025 to 31st December 2025.

The annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Background and objectives

The Patients Association is one of the oldest health and care charities in the United Kingdom. Founded in 1963, our remit is non-disease and non-condition specific; we work across issues that affect all and any patients. We work to ensure that everyone can access and benefit from the health and care they need. We connect directly with patients, giving us an insight into patient experience across the health and care system.

Our work engages:

We are in a period of deliberate internal transformation. While we continue our core work, we are making strategic choices about where we can achieve the greatest impact. This includes reviewing our patient engagement model including our helpline, developing focused national campaigns, and creating new ways to activate patients in our work for systemic change.

Our independence is our strength. Not part of the NHS, not tied to any specific condition, we exist to ensure that patient voices, including those least heard, shape a health and care system that works for everyone.

The state of the system in 2025

The health and care system is at a critical juncture. The government’s 10-Year Health Plan for England signals major transformation: shifting care from hospitals to communities, from analogue to digital, and from treatment to prevention. The Secretary of State for Health and Social Care promised a “revolution in patient power”, but transformation will only succeed if patients have the agency, knowledge, and support to navigate it effectively.

Just one in five people were satisfied with the NHS in the 2024 British Social Attitudes Survey. The Public Accounts Committee found that nearly 192,000 patients were waiting a year or more for care.

The reality patients face is stark. Behind these statistics are real people facing delays, uncertainty and distressing experiences, struggling to access primary care, long waiting hours in A&E, and receiving care in hospital corridors. What was once considered unacceptable has become normalised.

Page 3

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

We welcomed the Plan’s commitment to patient power, and were pleased to be recognised within it for our work on the NHS App. But it is not enough to just have our work acknowledged. The shifts being enacted - neighbourhood health, digital services, and prevention, will only benefit patients if they are designed and delivered with patients. This is precisely where the Patients Association’s role becomes more important. Our independence, our cross-condition reach, and our direct connections with a diverse range of patient communities position us to hold the system to account as that transformation unfolds.

A challenging year for charities

2025 was reported as one of the toughest financial years on record for the charity sector. For the Patients Association, the NHS spending freeze that began in late 2024 continued through much of 2025, significantly reducing commissioned project opportunities. Competition for shrinking Trust and Foundations funding intensified. The cost of living crisis affected both charitable income and operational costs.

What we did in 2025:

Patient engagement and partnership

Every message we deliver is rooted in what we hear from patients. In 2025, we grew our membership to 5,330 members, an 18% increase on the previous year, and we continue to hear directly and indirectly from patients about a wide range of issues that affected their care.

Patient Partnership Week returned for the fourth time in 2025. Seven webinars were delivered between 20th June and 4th July, covering topics from regulatory reform to digital innovation. One of the most popular sessions was a candid conversation with Sir Jim Mackey, Chief Executive of NHS England, a signal of the standing we have built as a trusted convener of patients and senior leaders.

Patient Partnership Week 2025 achieved a 63% increase in registrations and 74% increase in attendance on 2024, with 1,665 individuals registered and 864 attendants. 100% of speakers rated support as excellent and said they would participate again.

A webinar with Dr Rageshri Dhairyawan, author of Unheard: The Medical Practice of Silencing, attracted 185 registrants and 84 attendees (a 45% attendance rate, above the sector average). Drawing on her own experience of being denied pain relief as a patient, Dr Dhairyawan explored how systemic failures in listening are making people ill. Feedback on transcription and closed captions from attendees is already shaping how we make future sessions more accessible. Following on from this success, we will look to run another event with her next year.

We also delivered a webinar on helping patients prepare for healthcare appointments, chaired by Prof. Alf Collins, trustee of the Patients Association and former National Clinical Director for Personalised Care at NHS England. Joined by our Head of Partnerships and Involvement and two patients who shared their own experiences, the session walked through what patients can do before, during and after appointments to get the most from their care and prevent things going wrong. The webinar accompanied a guide and animation developed with funding from GSK, giving patients practical tools to navigate their care with confidence, which have been viewed 2,500 times.

Four of our webinars were also published on the newly launched Patients Association podcast: the fireside chat with Dr Rageshri Dhairyawan, the Patient Partnership Week sessions with Sir Jim Mackey, patient power, as well as our missingness webinar.

Our website had 198,496 views across 111,236 users in 2025, with the resources pages on getting a second opinion, seeing your medical records, next of kin, dentistry and making a complaint being the most popular.

Page 4

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Helpline

During 2025, our helpline responded to over 4,200 enquiries.

Access to medical records was one of the four themes that ran consistently through helpline enquiries, and the volume and nature of those contacts told a serious story. Our patient guide on accessing medical records was our most accessed resource on the website, with 794 downloads and over 15,000 page views in 2025. Many of these cases involved incorrect or missing diagnoses and treatments, with patients telling us errors were predominantly made by GPs. We responded publicly: "inaccuracies like these can lead to dangerous delays, misdiagnoses, and missed care, which is simply unacceptable. We need urgent improvements in how records are kept, shared, and corrected to safeguard both patient safety and public trust in the system." What our helpline hears directly informs what we say publicly, and this was a clear example of that in action.

Health equity

In December 2024 we published our Improving health equity for patients living with cancer and/or blood disorders report, funded by Bristol Myers Squibb. The report found that patients from underserved communities face compounding barriers from discrimination and delayed diagnosis to transport costs and a lack of information about their rights and available benefits. One consistent thread ran through every finding: patients not being listened to. In 2025, we turned those findings into action. We developed a factsheet and animation helping patients understand their rights, manage healthcare appointments, and access financial support. While developed from the cancer and blood disorders project, the resources are relevant to all patients. They were shared by Radiotherapy UK and featured on the British Asian Cancer Charity's YouTube channel and social media, extending our reach into communities we might not otherwise have accessed.

From feedback to action. Patients told us our resources would be more impactful in other languages. We listened, secured funding from GSK and Novartis, and are translating two patient guides into Arabic, Bengali, Portuguese, Punjabi, Romanian and Urdu - working with community members to ensure translations are culturally appropriate. Publishing in early 2026

The feedback we received was clear: our resources would reach further in other languages. We listened, and secured funding from GSK and Novartis to translate our ‘knowing your rights’ and ‘preparing for appointments’ guides into six languages: Arabic, Bengali, Portuguese, Punjabi, Romanian and Urdu. These communities experience significant health inequalities in the UK, so the project involves working directly with community members to identify barriers to accessing healthcare and ensure translations are culturally appropriate, not just linguistically accurate. Translation is underway and the results will be published and promoted widely in early 2026.

Policy influence

In 2025, we made further advancements in our policy work. In July, the 10-Year Health Plan for England was published and referenced our work as part of the Digital Coalition for Data and AI. Our policy recommendations were further validated in the public engagement with the 10 Year Health Plan reports, with direct patient feedback being pivotal to the design and delivery of the report. This is concrete evidence that our submissions are read and acted upon at the highest levels of national policy.

Our patient focus group research was also included in the final Leng Review report on Physician and Anaesthetist Associates, recognition that the evidence we gather directly from patients is credible and influential enough to inform formal clinical and regulatory policy. And when the government announced a review of the Carr-Hill formula, a direct recommendation from our health equity report, we welcomed it as confirmation that those patient voices had been heard.

Page 5

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

We published a report on reward, recognition and remuneration for patient involvement, commissioned by NHS England – East of England and shaped by the experiences of over 600 patients. As a result, it is now to be adopted by Integrated Care Boards across the East of England and has prompted further discussions between NHS England - East of England and NHS England and the National Institute for Health and Care Research.

In 2024, we were invited by the Department of Health and Social Care (DHSC) to join the Martha’s Rule policy sprints and subsequently in 2025, the Advisory Group, with participation from our Chair and Chief Executive. This involvement continued through to the successful pilot and national rollout of Martha’s Rule. We also contributed to the DHSC Patient Safety Commissioner advisory group, the National Data Advisory Group, the DHSC Elective Recovery Taskforce, and Module Six of the Covid Inquiry. Through these groups, we brought the patient voice to ongoing policy discussions and provided feedback that challenges the system to make the changes that patients want, need and deserve.

We responded to seven consultations in 2025, including the Digital Inclusion Action Plan, Shaping the National Cancer Plan, Building an NHS Fit for the Future, and proposals to regulate NHS managers. We ran our first Parliamentary drop-in event on patient choice, attended by the Shadow Secretary of State and senior political and health leaders.

The practice of treating patients in hospital corridors and other inappropriate spaces remained one of the most urgent issues of the year. Our patient survey fed directly into the Royal College of Emergency Medicine's report for the All-Party Parliamentary Group on corridor care, ensuring patient experience was at the heart of the clinical evidence.

We were also part of the Royal College of Nursing-led coalition of organisations representing clinicians, patients, carers and the public that wrote to NHS England calling for the urgent publication of corridor care data. The coalition's position was clear: meaningful progress on eradicating corridor care can only happen when there is honest transparency about its scale.

Media

Media engagement remained an important way for us to ensure patient perspectives were heard in national discussions about the future of health and care. During 2025 we issued 35 press releases, were approached 499 times for comment, and fulfilled 147 media requests, keeping the realities of patient experience visible across national broadcast, print and online coverage.

The government’s announcement that NHS England would be abolished prompted significant debate about how the health service should be organised. Our response emphasised that patients are primarily concerned with receiving high-quality care when they need it, rather than which organisation is responsible for overseeing the system. However, any structural reform must ultimately deliver meaningful improvements in patient care and experience.

Industrial action by resident doctors also generated sustained media interest throughout the year. We received 38 media requests on the issue and fulfilled 23, including live television interviews on Sky News and BBC News, radio interviews on BBC Radio 5 Live and LBC, and press commentary across national titles including The Guardian, The Daily Telegraph and The Times. As industrial action continued, we developed a tiered messaging framework to guide our response, ensuring our commentary remained focused on the impact on patients while recognising the wider challenges facing the NHS workforce. This approach was endorsed by trustees at the August 2025 Board meeting.

Page 6

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Digital and data

Our role in shaping the government's data pact went beyond consultation or comment. The DHSC and NHS England commissioned us to run the foundational focus groups, with our report on patient feedback being published.

Following our work, Thinks Data and Strategy ran a series of further public deliberations, with a draft data pact informed by our initial report. These deliberations ran through 2024 and 2025. We ensured patient voices were present, supporting patients to record short video clips sharing views and experiences, which were shown directly to deliberation participants.

We positioned patient partnership at the heart of national conversations through strategic platforms including Labour Party Conference, NHS ConfedExpo, Digital Health Rewired, and roundtables with the Secretary of State for Health and Social Care, the King's Fund, and the Royal Society of Medicine.

We ran our first Parliamentary drop-in event on patient choice alongside Arthritis UK and the Independent Health Providers Network, attended by senior political and health leaders.

Strategic development

In 2025, we developed our 2026–2030 organisational strategy, providing a strong foundation for our work and impact over the next five years. With pro-bono support from The Berkeley Partnership, we examined four potential strategic models and committed to four core services:

2026 is our foundational year. Three workstreams will shape how we deliver our mission:

This is not business as usual. While we continue to build from our core model, 2026 represents the first step in a phased transformation: one that will make our unique cross-system role more focused, more measurable, and more powerful for the patients who need us most.

Funded work

In 2025, we delivered 18 funded projects, working with NHS organisations, industry, and regulators. Projects spanned patient experience and feedback, policy development, accessibility improvements, service redesign, patient advisory services, and communications campaigns. Across each project, we ensured that the voices of patients, including those from marginalised and underrepresented backgrounds were central to the work. Working with regulators was a particular feature of the year. We were commissioned by Health Services Safety Investigations Body (HSSIB) and The Health and Care Professions Council (HCPC) to facilitate patient involvement in the development of its patient engagement and organisational strategies, ensuring those responsible for patient safety are guided by what matters to those most affected.

Page 7

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

We also improved the accessibility of our own resources. With funding from EIDO, we added British sign language interpretation to two animations on Patient Partnership and Shared Decision-Making ensuring that deaf patients can access content that is directly relevant to their care. This sits alongside our translation of patient information guides and reflects a broader commitment to continually learning from emerging best accessibility, practice and innovation.

Financial Review

We ended 2025 with a deficit of £61K.

Our income comes from a variety of sources including:

The Patients Association is registered with the Fundraising Regulator and has fully adopted and is committed to its code of best fundraising practice. In addition, the Trustees and staff ensure we work to an ethical fundraising policy and process. We have received no complaints about our fundraising and do not fundraise from individuals in any way that could be seen as intrusive on a person's privacy or to place pressure on any person to donate.

The Trustees receive full disclosure on a quarterly basis of all fundraising activities undertaken by the Association. At present the Association has not and does not have plans to engage external services of a professional or commercial fundraiser.

Reserves policy

The Trustees review the reserves policy annually. In 2025, the Association moved away from a time-based calculation (a flat rate of six months' operating costs) to a risk-based approach. The reserve target is now calculated by combining the estimated impact of a 'grey swan' event - a high-impact, low-probability occurrence such as a major national emergency - with the two principal financial risks held on the Association's risk register. For 2025, these produce a reserves target of £275k (2024: £279k).

This reserves figure includes provision for project expenses to ensure that, in the event of financial difficulties, the charity would have sufficient funds to complete any outstanding project commitments while maintaining core operations during the transition period.

Page 8

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Free reserves

The sum of the reserves levels makes up the unrestricted funds shown in the accounts.

The outcome for the year ending 31 December 2025 was a deficit of £60,811. This compares to a surplus in 2024 of £79,070. (Surplus £88,295 in 2023).

The balance held in unrestricted funds at the 31 December 2025 was £415,541. This compares to a balance in 2024 of £476,352. (£397,282 in 2023). The target reserves level for 2026 is £275k.

Restricted reserves

Restricted reserves relate to monies received where the donor has specified what the funds must be used for. There were no restricted reserves at the end of 2025.

Investment policy

In 2025 the Board of Trustees approved a formal Investment Policy. The Association holds its investments in the CCLA Charities Deposit Fund, a regulated pooled fund designed for charities. The fund is professionally managed, tax efficient, and redeemable on a daily basis. The Association sets a target return of CPI +1% and invests according to four principles: security, liquidity, ethical considerations, and yield. Capital is not put at risk under the current investment vehicle.

Structure, Governance, and Management Legal and Administrative Information

The Patients Association is a registered company limited by guarantee, company number 02620761 registered in England and Wales. It is also a registered Charity, number 1006733. The Charity was established under a memorandum and articles of association.

Public benefit

When reviewing the Association’s aims and objectives and planning current and future activities, we have referred to the Charity Commission's general guidance on public benefit. In particular, the Trustees consider how the Association’s activities will contribute to objectives for the benefit of patients.

Governance and management

The Trustees continue in their commitment to achieving the highest possible standards by demonstrating exemplary leadership and governance. The Association continues structured recruitment procedures for staff and trustees that ensure diversity of skills and perspectives, regular risk register reviews conducted at both Finance and Resources Committee and Board levels, and staff appraisals.

Page 9

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Principal risks and uncertainties

The Board maintains a robust approach to risk management, regularly reviewing the risk register to ensure the organisation is well-governed and resilient. Risks are scored according to likelihood and impact, with the highestrated areas in 2025 spanning financial sustainability, people and capacity, and technology and data. Financial resilience remains the most closely monitored priority, with measures in place to ensure the Association continues to deliver for patients. The Association continues to invest in attracting and retaining the skilled staff and trustees essential to the strategy, while actively managing risks around patient data protection, IT resilience, fraud, and the responsible use of artificial intelligence.

The Board of Trustees maintains rigorous oversight of risk, ensuring that appropriate controls are in place to protect the organisation, staff, and the funds entrusted to the organisation’s care.

Board of Trustees

The Board is responsible and accountable to the Association’s members, the Charity Commission, funders, stakeholders, and for compliance with charity and company law. It is responsible for setting the strategic direction and for the financial management of the Association, setting the annual budget, and compiling the annual report and accounts.

The Chief Executive is accountable to the Board of Trustees for delivery of the strategy and presents an update against progress in delivering the Association’s objectives at each board meeting.

Diversity

The Board is committed to ensuring the organisation represents a diverse range of skills, experience, and background.

The Association’s diversity objectives are:

Board recruitment

Appointments to the Board continue to be via an open and formal recruitment process. The recruitment process includes a skills audit of the Board of Trustees to identify gaps, an open and transparent process with formal interviews, and eligibility checks including fit and proper person, references and identify checks.

Board meetings

The Board of Trustees meets four times a year. The Finance and Resources Committee, which reports to the Board of Trustees, also meets four times a year.

Supporting staff and volunteers

During 2025, the Association continued to work hard on the wellbeing and engagement of staff and volunteers. It has one volunteer supporting the work of the organisation.

Page 10

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Remuneration of key personnel

The Patients Association recognises the motivation of its staff team to work within the charitable sector and aims to strike a balance between paying enough to recruit and keep people with the skills needed, and the public and donors' expectations that the money entrusted to us will be used wisely.

The Remuneration policy sets out the approach of the Patients Association to setting remuneration levels to be able to recruit and retain staff with the appropriate skills and experience needed to meet the requirements of our charitable objectives and to deliver our agreed strategic objectives.

The Board of Trustees is ultimately responsible for setting the remuneration levels of the Chief Executive in line with the skills, experience, and competencies required to meet the requirements of the Patients Association's purpose and deliver the agreed strategic objectives. It does this by a thorough review of the skills needed, benchmarking against other organisations and consideration of the sustainability of the organisation.

The Trustees' Annual Report

The Trustees' Annual Report has been prepared in accordance with the provisions applicable to entities subject to the small companies' regime.

Approved by order of the members of the board of Trustees on and signed on their behalf by:

Julie Thallon

................................................

Mrs J Thallon,

Chair of the Board of Trustees

Date: 19th June 2026

Page 11

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees and signed on its behalf by:

Julie Thallon

................................................ Julie Thallon Chair Date: 19th June 2026

Page 12

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025

Independent Examiner's Report to the Trustees of The Patients Association ('the Charity')

I report to the charity Trustees on my examination of the accounts of the charity for the year ended 31 December 2024.

Responsibilities and Basis of Report

As the Trustees of the Charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe in any material respect:

  1. accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act, other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Signed: Dated: 16 June 2026

Rachel Doyle

ACA DChA

MHA MHA House Charter Court Swansea Enterprise Park Swansea SA7 9FS

MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542).

Page 13

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2025

Note
Income from:
Donations and legacies
4
Charitable activities
5
Other trading activities
6
Investments
7
Total income
Expenditure on:
Raising funds
8
Charitable activities
9
Total expenditure
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward
Unrestricted
funds
2025
£
272,807
245,911
21,562
7,517
547,797
123,541
485,067
608,608
(60,811)
476,352
(60,811)
415,541
Restricted
funds
2025
£
-
17,624
-
-
17,624
-
17,624
17,624
-
-
-
-
Total
funds
2025
£
272,807
263,535
21,562
7,517
565,421
123,541
502,691
626,232
(60,811)
476,352
(60,811)
415,541
Total
funds
2024
£
404,351
283,354
11,390
9,497
708,592
112,464
517,058
629,522
79,070
397,282
79,070
476,352

Page 14

THE PATIENTS ASSOCIATION (A Company Limited by Guarantee) REGISTERED NUMBER: 02620761

BALANCE SHEET AS AT 31 DECEMBER 2025

Fixed assets
Note
Tangible assets
13
Current assets
Debtors
14
Cash at bank and in hand
Current liabilities
Creditors: amounts falling due within one
year
15
Net current assets
Total net assets
Charity funds
Unrestricted funds
16
Total funds
2025
£
86,262
375,714
461,976
(49,402)
2025
£
2,967
2,967
412,574
415,541
415,541
415,541
2024
£
127,846
375,228
503,074
(30,422)
2024
£
3,700
3,700
472,652
476,352
476,352
476,352

The Charity was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Julie Thallon

................................................

Julie Thallon

Chair Date: 19th June 2026

The notes on pages 17 to 31 form part of these financial statements.

Page 15

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2025

Cash flows from operating activities
Net cash used in operating activities
Cash flows from investing activities
Investment income
Purchase of tangible fixed assets
Net cash provided by investing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
The notes on pages 17 to 31 form part of these financial statements
2025
£
(6,280)
7,517
(752)
6,765
485
375,229
375,714
2024
£
51,492
9,497
(3,581)
5,916
57,408
317,821
375,229

Page 16

THE PATIENTS ASSOCIATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1. General information

The Patients Association is a company limited by guarantee and is registered with the Charity Commission (Charity Registered Number 1006733) and Registrar of Companies (Company Registration Number 02620761) in England and Wales. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity. The address of the registered office is given in the Charity information on page 1 of these financial statements. The nature of the Charity’s operations and principal activities are detailed in the Trustees’ Report.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The Patients Association meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The financial statements are presented in sterling, which is the functional and presentational currency and are rounded to the nearest pound.

2.2 Going concern

The Trustees have assessed the use of going concern and have considered possible events or conditions that might cast significant doubt on the ability of the Charity to continue as a going concern. The Trustees have made this assessment for a period of at least one year from the date of the approval of these financial statements. The Trustees have concluded that there is a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. The Charity, therefore, continues to adopt the going concern basis in preparing these financial statements.

Page 17

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.3 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Donations are accounted for when received.

Corporate membership income is included within donations and is recognised when received, as these amounts are given without performance related conditions and are treated as voluntary income.

Trading income arises from fundraising events and other revenue generating activities. Income is recognised when earned, based on the delivery of the related goods or services.

Grants, including government grants, are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Gifts in kind donated for distribution are included at valuation and recognised as income when they are distributed to the projects. Gifts donated for resale are included as income when they are sold.

On receipt, donated professional services and facilities are recognised on the basis of the value of the gift to the Charity which is the amount it would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

Legacy income is recognised in the Statement of Financial Activities when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. If legacy income cannot be quantified with reasonable accuracy, a contingent asset disclosure is included in the notes to the accounts.

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

Page 18

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Taxation

The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and, therefore, it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

2.7 Tangible fixed assets and depreciation

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

At each reporting date the Charity assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined to be the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Fixtures, fittings and equipment - 25% straight line or reducing balance Computer equipment - 33% straight line or reducing balance

2.8 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.9 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Page 19

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.10 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

2.11 Financial instruments

The only financial assets and financial liabilities are of a kind that qualify as basic financial instruments. The financial assets and financial liabilities of the Charity are as follows:

Debtors – trade and other debtors (including accrued income) are basic financial instruments and are debt instruments measured at amortised cost as detailed in Note 14. Prepayments are not financial instruments.

Cash at bank – is classified as a basic financial instrument and is measured at face value.

Liabilities – trade creditors, accruals and other creditors will be classified as financial instruments, and are measured at amortised cost as detailed in Note 15. Taxation and social security are not included in the financial instruments disclosure. Deferred income is not deemed to be a financial liability, as in the cash settlement has already taken place and there is simply an obligation to deliver charitable services rather than cash or another financial instrument.

2.12 Operating leases

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the lease term.

2.13 Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

Contributions are expensed as they become payable. This expenditure is allocated to an activity and fund based on the department that member of staff works in.

2.14 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 20

THE PATIENTS ASSOCIATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

3. Critical accounting estimates and areas of judgment

Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Critical accounting estimates and assumptions:

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are listed below.

4. Income from donations and grants

Donations and grants
Corporate donations/ membership
Legacy donations
Total 2025
Donations and grants
Corporate donations/membership
Legacy donations
Total 2024
Unrestricted
funds
2025
£
8,434
263,000
1,373
272,807
Unrestricted
funds
2024
£
5,683
189,168
209,500
404,351
Total
funds
2025
£
8,434
263,000
1,373
272,807
Total
funds
2024
£
5,683
189,168
209,500
404,351

Page 21

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

5. Income from charitable activities

Helpline and Information Services
Performance-related grants
Total 2025
Helpline and Information Services
Performance-related grants
Total 2024
Unrestricted
funds
2025
£
17,500
228,411


Restricted
funds
2025
£
-
17,624
17,624
Unrestricted
funds
2024
£
17,500
265,854
283,354
Total
funds
2025
£
17,500
246,035
245,911 263,535
Total
funds
2024
£
17,500
265,854
283,354

6. Income from other trading activities Income from fundraising events

Event income
Event income
Unrestricted
funds
2025
£
21,562
Unrestricted
funds
2024
£
11,390
Total
funds
2025
£
21,562
Total
funds
2024
£
11,390

Page 22

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

7. Investment income

Bank interest receivable
Bank interest receivable
Expenditure on raising funds
Direct costs - Staff costs
Direct costs - Staff costs
Unrestricted
funds
2025
£
7,517
Unrestricted
funds
2024
£
9,497
Unrestricted
funds
2025
£
123,541
Unrestricted
funds
2024
£
112,463
Total
funds
2025
£
7,517
Total
funds
2024
£
9,497
Total
funds
2025
£
123,541
Total
funds
2024
£
112,463

8. Expenditure on raising funds

Page 23

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

9. Analysis of expenditure by charitable activities

Helpline and Information Services
Influencing Policy and Practice
Total 2025
Helpline and Information Services
Influencing Policy and Practice
Total 2024
Activities
undertaken
directly
2025
£
157,771
283,000
440,771
Activities
undertaken
directly
2024
£
149,625
300,417
450,042
Support
costs
2025
£
21,991
39,929
61,920
Support
costs
2024
£
22,337
44,679
67,016
Total
funds
2025
£
179,762
322,929
502,691
Total
funds
2024
£
171,962
345,096
517,058

Page 24

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

9. Analysis of expenditure by charitable activities (continued)

Analysis of support costs

Depreciation
Rent and rates
Recruitment expenses
Communication costs
Consultancy costs
Advertising and marketing
Travel and subsistence
Printing, postage and stationery
Subscriptions
Bank charges
Governance costs
Other costs
Total 2025
Governance costs are analysed in Note 10.
Total
funds
2025
£
1,483
5,092
28
21,511
7,131
2,478
4,306
665
1,485
49
15,291
2,401
61,920
Total
funds
2024
£
1,848
2,455
2,291
21,644
12,316
2,030
3,891
758
1,587
74
13,216
4,906
67,016

10. Governance costs

Insurance
Independent Examiners' Remuneration
Bookkeeping & accountancy costs
Other costs
2025
£
3,228
4,700
7,325
38
15,291
2024
£
2,071
2,930
7,150
1,065
13,216

Page 25

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

11. Staff costs

Wages and salaries
Social security costs
Pension scheme contributions
2025
£
394,293
38,732
12,149
445,174
2024
£
371,700
32,923
10,947
415,570

The average number of persons employed by the Charity during the year was as follows:

2025 2024
No. No.
Staff 10 10

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2025 2024
No. No.
In the band £80,001 - £90,000 1 1

The total amount of employee benefits, including employers social security costs, received by Key Management Personnel of the Charity was £98,031 (2024: £92,695). The Charity considers its Key Management Personnel to comprise of the Trustees and the Chief Executive Officer. As disclosed in Note 12, no Trustees received any remuneration or other benefits during the year (2024: £NIL).

12. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2024 - £NIL) .

During the year ended 31 December 2025, £1,103 of expenses were reimbursed to 1 Trustee (2024: £ 196 to 1 trustee). These reimbursements were for meeting and travelling costs.

Page 26

THE PATIENTS ASSOCIATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

13. Tangible fixed assets

Cost or valuation
At 1 January 2025
Additions
At 31 December 2025
Depreciation
At 1 January 2025
Charge for the year
At 31 December 2025
Net book value
At 31 December 2025
At 31 December 2024
Computer
equipment
£
9,292
752
10,044
5,593
1,484
7,077
2,967
3,699

Page 27

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

14. Debtors

Due within one year
Trade debtors
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income
2025
£
59,788
-
42
26,432
86,262
2024
£
53,812
3
31
74,000
127,846

15. Creditors: Amounts falling due within one year

Trade creditors
Other taxation and social security
Accruals and deferred income
Deferred income
Resources deferred during the year
Amounts released from previous periods
Deferred income at 31 December 2025
2025
£
1,688
26,938
20,776
49,402
2025
£
12,432
-
12,432
2024
£
860
23,531
6,031
30,422
2024
£
-
-
-

Deferred income represents income received in 2025 for projects & corporate membership relating to the following financial reporting period.

Page 28

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

16. Statement of funds

Statement of funds - current year

Balance at 1
January
2025
£
Income
£
Unrestricted funds
General unrestricted funds
476,352
547,797
Restricted funds
GSK Grant
-
17,624
Total of funds
476,352
565,421
Restricted funds:
GSK Grant
This grant was to support the translation of patient information resources.
Statement of funds - prior year
Unrestricted funds
Balance at
1 January
2024
£
Income
£
General unrestricted funds
397,282
708,592
Expenditure
£
(608,608)
(17,624)
(626,232)
Expenditure
£
(629,522)
Balance at
31
December
2025
£
415,541
-
415,541
Balance at
31
December
2024
£
476,352

Unrestricted funds are general funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Page 29

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

17. Analysis of net assets between funds

Analysis of net assets between funds - current year

Tangible fixed assets
Current assets
Creditors due within one year
Total
Analysis of net assets between funds - prior year
Tangible fixed assets
Current assets
Creditors due within one year
Total
Unrestricted
funds
2025
£
2,967
461,976
(49,402)
415,541
Unrestricted
funds
2024
£
3,700
503,074
(30,422)
476,352
Total
funds
2025
£
2,967
461,976
(49,402)
415,541
Total
funds
2024
£
3,700
503,074
(30,422)
476,352

18. Reconciliation of net movement in funds to net cash flow from operating activities

Net income/expenditure for the year (as per Statement of Financial
Activities)
Adjustments for:
Depreciation charges
Investment income
(Increase)/ decrease in debtors
Increase/ (decrease) in creditors
Net cash provided by/(used in) operating activities
2025
£
(60,811)
1,484
(7,517)
41,584
18,980
(6,280)
2024
£
79,070
1,848
(9,497)
(7,130)
(12,799)
51,492

Page 30

(A Company Limited by Guarantee)

THE PATIENTS ASSOCIATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

19. Analysis of cash and cash equivalents

Cash in hand
Total cash and cash equivalents
2025
£
375,714
375,714
2024
£
375,229
375,229

20. Analysis of changes in net debt

Cash at bank and in hand At 1
January
2025
£
375,228
375,228
Cash flows
£
486
486
At 31
December
2025
£
375,714
375,714

21. Pension commitments

The charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund. The pension cost charge represents contributions payable by the charity to the fund and amounted to £12,149 (2024: £10,964) in the year. An amount of £1,942 (2024: £1,874) was due to the independently administered fund at the year end.

22. Trustees liability

Each Trustee of the charitable company undertakes to contribute to the assets of the company in the event of it being wound up while they are a Trustee, or within one year after they cease to be a Trustee, such amount as may be required, not exceeding £1 for the debts and liabilities contracted before they cease to be a Trustee.

23. Related party transactions

Other than Trustee and Key Management Personnel transactions detailed in Notes 11 and 12, there were no other related party transactions during the period (2024: None).

Page 31